Related Experiment Video
Updated: Feb 13, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Pulmonary artery leiomyosarcoma: A clinical dilemma
Nilgün Yilmaz Demirci1, Nurgül Naurzvai1, Ismail Kirbaş2
1Department of Chest Disease, Faculty of Medicine, Gazi University, Ankara, Turkey.
Primary pulmonary leiomyosarcoma is a rare and lethal lung cancer. This case highlights a rapidly growing tumor with extensive local invasion, emphasizing diagnostic delays.
Area of Science:
- Oncology
- Pulmonology
- Pathology
Background:
- Primary pulmonary leiomyosarcomas are exceptionally rare lung malignancies, accounting for 0.2%-0.5% of all primary lung cancers.
- These tumors arise from smooth muscle cells in the bronchi, vasculature, or interstitium, presenting diagnostic challenges due to nonspecific symptoms and infrequent occurrence.
Observation:
- A case of a rapidly progressing primary pulmonary leiomyosarcoma is presented.
- The tumor demonstrated extensive local invasion into the right atrium, superior vena cava, mediastinum, hilar area, and left pulmonary artery within a four-month period.
Findings:
- Histopathological analysis via transthoracic needle biopsy confirmed the diagnosis of leiomyosarcoma.
- Delayed diagnosis contributed to significant local spread to adjacent thoracic structures.
Implications:
- This case underscores the aggressive nature and potential for rapid, extensive local invasion of primary pulmonary leiomyosarcoma.
- Timely diagnosis and management are critical for improving outcomes in patients with this rare and aggressive neoplasm.
More Related Videos
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
Related Concept Videos
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Dilemmas II
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Coronary Artery Disease III: Clinical Manifestations
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...